← Back to Clinical Trials
Recruiting NCT06985836

NCT06985836 Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06985836
Status Recruiting
Phase
Sponsor Riphah International University
Condition Adhesive Capsulitis
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2024-12-15
Primary Completion 2025-05-15

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Mulligan Mobilization and Niel Asher techniqueMulligan Mobilization and Conventional physiotherapy.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2024-12-15 with a primary completion date of 2025-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Adhesive capsulitis is a prevalent condition characterized by pain and stiffness in shoulder joint and surrounding muscles shows decrease range and strength in patients with adhesive capsulitis. This study aims to determine the effect of mulligan mobilization with or without Niel Asher technique on pain, range of motion and disability in patients with adhesive capsulitis. This study will be a randomized controlled trial and will be conducted in Ibne-siena Hospital Multan and Multicare physiotherapy clinic. Non-probability convenience sampling will be used to collect the data. Sample size of subjects with age group between 40 to 60 years will be taken. Data will be collected from the patients having present complaint of adhesive capsulitis. Outcome measures used will be Numeric pain rating scale (NPRS) for shoulder pain and SPADI for shoulder disability and Universal Goniometer (GU) for Range of motion. An informed consent will be taken. Subjects will be selected on the basis of inclusion and exclusion criteria. Subjects will be divided into two groups by random number generator table. Both the Groups will receive heating pad, TENS. Group A will receive Mulligan Mobilizations and Neil Asher technique, and Group B will receive Mulligan mobilization and Conventional Treatment. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 26.

Eligibility Criteria

Inclusion Criteria: * Age group 40-60 year * Both gender male and female * Stage 2 primary adhesive capsulitis with capsular pattern of restriction (rotation\>abduction\>flexion) * Pain in shoulder should be ≤7 on NPRS * Patient is willing to perform. Exclusion Criteria: * • Diabetes * Malignancy * Infection * Arthoplasty * Pregnancy * Neurological disorders * Fracture * Thyroid diseases

Contact & Investigator

Central Contact

Iqbal Tariq, PHD

✉ Iqbal.tariq@riphah.edu.pk

📞 03338236752

Principal Investigator

Rabiya Noor, PHD

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06985836 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06985836 currently recruiting?

Yes, NCT06985836 is actively recruiting participants. Contact the research team at Iqbal.tariq@riphah.edu.pk for enrollment information.

Where is the NCT06985836 trial being conducted?

This trial is being conducted at Multan Khurd, Pakistan.

Who is sponsoring the NCT06985836 clinical trial?

NCT06985836 is sponsored by Riphah International University. The principal investigator is Rabiya Noor, PHD at Riphah International University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology